Amy Weise Selected Research

Everolimus

12/2020

Phase Ib Dose-escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women with HR+, HER2- Advanced Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Amy Weise Research Topics

Disease

9	Neoplasms (Cancer) 01/2022 - 01/2007
4	Vomiting 01/2022 - 10/2016
4	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2007
3	Fatigue 01/2022 - 10/2016
3	Nausea 01/2021 - 10/2016
2	Dehydration (Water Stress) 01/2022 - 01/2019
2	Diarrhea 11/2021 - 10/2016
2	Melanoma (Melanoma, Malignant) 01/2021 - 10/2016
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2019 - 12/2018
1	Abdominal Pain (Pain, Abdominal) 01/2022
1	Hypertriglyceridemia 01/2022
1	Anemia 01/2022
1	Carcinoma (Carcinomatosis) 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Carcinogenesis 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 02/2019
1	Pneumonia (Pneumonitis) 02/2019
1	Chromosomal Instability (Chromosome Stability) 01/2019
1	Exanthema (Rash) 10/2016
1	Edema (Dropsy) 10/2016

Drug/Important Bio-Agent (IBA)

2	Immune Checkpoint InhibitorsIBA 11/2021 - 02/2019
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 12/2020
2	MLN 8237IBA 01/2019 - 12/2018
2	Aurora Kinase AIBA 01/2019 - 12/2018
1	DepsipeptidesIBA 01/2022
1	BilirubinIBA 01/2022
1	YM753 compoundIBA 01/2022
1	varlilumabIBA 01/2022
1	TransferasesIBA 01/2022
1	NivolumabIBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	Histone Deacetylase InhibitorsIBA 01/2022
1	RAD140IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 11/2021
1	Lipase (Acid Lipase)FDA Link 11/2021
1	TabletsIBA 01/2021
1	RO6870810IBA 01/2021
1	RAD1901IBA 01/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2021
1	Phosphorus (Red Phosphorus)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Estrogen ReceptorsIBA 01/2021
1	elacestrantIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	ribociclibIBA 12/2020
1	Everolimus FDA Link 12/2020
1	exemestane (Aromasin)FDA Link 12/2020
1	Hormones (Hormone)IBA 12/2020
1	Monoclonal AntibodiesIBA 01/2019
1	Granzymes (Granzyme)IBA 01/2019
1	PlatinumIBA 01/2019
1	cobimetinibIBA 10/2016
1	VaccinesIBA 07/2015
1	Heterophile AntigensIBA 01/2010
1	Cancer VaccinesIBA 01/2010
1	EpitopesIBA 01/2010
1	AutoantigensIBA 01/2010
1	DNA VaccinesIBA 01/2010
1	AntigensIBA 01/2010
1	DNA (Deoxyribonucleic Acid)IBA 01/2007
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2007
1	Dinoprostone (PGE2)FDA Link 01/2007

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2019
1	Intravenous Infusions 01/2022
1	Immunotherapy 01/2021
1	Nephrectomy 02/2019